Skip to main content
Equibles

VIVANZA · Vivanza Biosciences Limited · Financials

Use VIVANZA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research VIVANZA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
1.48 INR +0.01 (+0.68%) At close · Nov 12
Rebalance outlook locked
Market Cap
59.20M INR
Shares
40.00M
Volume · Nov 12 17.53K Avg daily vol (3M) 24.59K

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Pull these statements through the financial statements API or MCP →
Revenue
1.16B +1461.4%
FY2026 Revenue FY2025–FY2026
Net Income
3.94M
FY2026 Net Income FY2025–FY2026
Operating Cash Flow
-12.6M +49.6%
FY2026 Operating Cash Flow FY2025–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item TTM FY2026 FY2025
INR 723.16M 1.16B 74.23M
INR 253K 216K 140K
INR 3.06M 2.79M 3.51M
INR 2.45M 5.44M -6.66M
INR 2.17M 1.49M 84K
INR -1.68M 3.94M 0
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2025–FY2026: 0 in dividends.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.